Journal Mobile Options
Table of Contents
Vol. 81, Suppl. 1, 2002
Issue release date: 2002

Molecular Interactions in Pulmonary Surfactant Films

Pérez-Gil J.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Pulmonary surfactant is a lipid-protein complex which has the essential physiological role of stabilizing the respiratory surface of lungs against collapse. To achieve this function, surfactant forms films at the air-liquid interface that reduce dramatically the surface tension of the thin aqueous layer lining the alveoli. Natural surfactant has optimised two important properties. Once secreted to the alveolar spaces, surfactant adsorbs rapidly to the interface. There, surfactant films reduce surface tension close to 0 mN/m when compressed during expiration. The design and production of efficient artificial surfactants for respiratory therapeutics is critically dependent on the knowledge of the molecular mechanisms governing efficient interfacial adsorption and optimal surface activity, in the context of respiratory cycling. The present review summarizes the data available today on the behaviour of the different molecular components of pulmonary surfactant at air-liquid interfaces. A working model is proposed of how surfactant films could modulate the respiratory dynamics.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Frerking I, Günther A, Seeger W, Pison U: Pulmonary surfactant: functions, abnormalities and therapeutic options. Intensive Care Med 2001;27:1699–1717.

    External Resources

  2. Jobe AH, Ikegami M: Biology of surfactant. Clin Perinatol 2001;28:655–669.
  3. Hallman M, Glumoff V, Ramet M: Surfactant in respiratory distress syndrome and lung injury. Comp Biochem Physiol 2001;129:287–294.
  4. Seeger W, Günther A, Walmrath HD, Grimminger F, Lasch HG: Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects. Clin Invest 1993;71:177–190.
  5. Robertson B, Halliday HL: Principles of surfactant replacement. Biochim Biophys Acta 1998;1408:346–361.
  6. Günther A, Ruppert C, Schmidt R, Markart P, Grimminger F, Walmrath D, Seeger W: Surfactant alteration and replacement in acute respiratory distress syndrome. Respir Res 2001;2:353–364.
  7. Walmrath D, De Vaal JB, Bruining HA, Killian JG, Papazina L, Hohlfeld J, Vogelmeier C, Wurst W, Schaffer P, Rathgeb F, Grimminger F, Seeger W: Treatment of ARDS with a recombinant SP-C (rSP-C) based synthetic surfactant. Am J Respir Crit Care Med 2000;161:A379.
  8. Goerke J: Pulmonary surfactant: Functions and molecular composition. Biochim Biophys Acta 1998;1408:79–89.
  9. Veldhuizen R, Nag K, Orgeig S, Possmayer F: The role of lipids in pulmonary surfactant. Biochim Biophys Acta 1998;1408:90–108.
  10. Haagsman HP, Diemel RV: Surfactant-associated proteins: functions and structural variation. Comp Biochem 2001;129:91–108.
  11. Crouch E, Wright JR: Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 2001;63:521–554.
  12. Weaver TE, Conkright JJ: Function of surfactant proteins B and C. Annu Rev Physiol 2001;63:555–578.
  13. Weaver TE: Synthesis, processing and secretion of surfactant proteins B and C. Biochim Biophys Acta 1998;1408:173–179.
  14. Casals C: Role of surfactant protein A (SP-A)/lipid interactions for SP-A functions in the lung. Pediatr Pathol Mol Med 2001;20:249–268.
  15. Ikegami M, Korfhagen TR, Whitsett JA, Bruno MD, Wert SE, Wada K, Jobe AH: Characteristics of surfactant from SP-A-deficient mice. Am J Physiol 1998;275:L247–L254.

    External Resources

  16. Korfhagen TR, Bruno MD, Ross GF, Huelsman KM, Ikegami M, Jobe AH, Wert SE, Stripp BR, Morris RE, Glasser SW, Bachurski CJ, Iwamoto HS, Whitsett JA: Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci U S A 1996;93:9594–9599.
  17. Cockshutt AM, Weitz J, Possmayer F: Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro. Biochemistry 1990;29:8424–849.

    External Resources

  18. Bridges JP, Davis HW, Damodarasamy M, Kuroki Y, Howles G, Hui DY, McCormack FX: Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury. J Biol Chem 2000;275:38848–38855.
  19. Pérez-Gil J, Keough KMW: Interfacial properties of surfactant proteins. Biochim Biophys Acta 1998;1408:203–217.
  20. Clements J: Surface tensions of lung extracts. Proc Soc Exp Biol Med 1957;95:170–172.
  21. Schürch S, Goerke J, Clements JA: Direct determination of volume- and time-dependence of alveolar surface tension in excised lungs. Proc Natl Acad Sci USA 1978;75:3417–3421.
  22. Takamoto DY, Lipp MM, von Nahmen A, Lee KY, Waring AJ, Zasadzinski JA: Interaction of lung surfactant proteins with anionic phospholipids. Biophys J 2001;81:153–169.

    External Resources

  23. Magoon MW, Wright JR, Baritussio A, Williams MC, Goerke J, Benson BJ, Hamilton RL, Clements JA: Subfractionation of lung surfactant. Implications for metabolism and surface activity. Biochim Biophys Acta 1983;750:18–31.
  24. Massaro GD, Massaro D: Morphologic evidence that large inflations of the lung stimulate secretion of surfactant. Am Rev Respir Dis 1983;127:235–236.

    External Resources

  25. Dietl P, Haller T, Mair N, Frick M: Mechanisms of surfactant exocytosis in alveolar type II cells in vitro and in vivo. News Physiol Sci 2001;16:239–243.

    External Resources

  26. Suzuki Y, Fujita Y, Kogishi K: Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant. Am Rev Respir Dis 1989;140:75–81.
  27. Williams MC, Hawgood S, Hamilton RL: Changes in lipid structure produced by surfactant proteins SP-A, SP-B, and SP-C. Am J Respir Cell Mol Biol 1991;5:41–50.
  28. Poulain FR, Allen L, Williams MC, Hamilton RL, Hawgood S: Effects of surfactant apolipoproteins on liposome structure: implications for tubular myelin formation. Am J Physiol 1992;262:L730–L739.

    External Resources

  29. Williams MC: Morphologic aspects of the surfactant system; in Robertson B, van Golde LMG, Batenburg JJ (eds): Pulmonary Surfactant: From Molecular Biology to Clinical Practice. Amsterdam, Elsevier, 1992, pp 87–107.
  30. Pérez-Gil J, Tucker J, Simatos G, Keough KMW: Interfacial adsorption of simple lipid mixtures combined with hydrophobic surfactant protein from pig lung. Biochem Cell Biol 1992;70:332–338.
  31. Schram V, Hall SB: Thermodynamic effects of the hydrophobic surfactant proteins on the early adsorption of pulmonary surfactant. Biophys J 2001;81:1536–46.

    External Resources

  32. Notter RH, Finkelstein JN, Taubold RD: Comparative adsorption of natural lung surfactant, extracted phospholipids, and artificial phospholipid mixtures to the air-water interface. Chem Phys Lipids 1983;33:67–80.
  33. Oosterlaken-Dijksterhuis MA, Haagsman HP, van Golde LMG, Demel RA: Characterization of lipid insertion into monomolecular layers mediated by lung surfactant proteins SP-B and SP-C. Biochemistry 1991;30:10965–10971.

    External Resources

  34. Oosterlaken-Dijksterhuis MA, Haagsman HP, van Golde LMG, Demel RA: Interaction of lipid vesicles with monomolecular layers containing lung surfactant proteins SP-B or SP-C. Biochemistry 1991;30:8276–8281.

    External Resources

  35. Wang Z, Hall SB, Notter RH: Roles of different hydrophobic constituents in the adsorption of pulmonary surfactant. J Lipid Res 1996;37:790–798.
  36. Higuchi R, Lewis J, Ikegami M: In vitro conversion of surfactant subtypes is altered in alveolar surfactant isolated from injured lungs. Am Rev Respir Dis 1992;145:1416–1420.
  37. Sen A, Hui SW, Mosgrober AM, Holm BA, Egan EA. J Colloid Interface Sci 1988;126:355–360.
  38. Schürch S, Green FH, Bachofen H: Formation and structure of surface films: captive bubble surfactometry. Biochim Biophys Acta 1998;1408:180–202.
  39. Schürch S, Qanbar R, Bachofen H, Possmayer F: The surface-associated surfactant reservoir in the alveolar lining. Biol Neonate 1995;67:61–76.

    External Resources

  40. Possmayer F, Nag K, Rodriguez K, Qanbar R, Schürch S: Surface activity in vitro: role of surfactant proteins. Comp Biochem Physiol 2001;129:209–220.
  41. Cruz A, Casals C, Keough KMW, Pérez-Gil J: Different modes of interaction of pulmonary surfactant protein SP-B in phosphatidylcholine bilayers. Biochem J 1997;327:133–138.
  42. Chang R, Nir S, Poulain FR: Analysis of binding and membrane destabilization of phospholipid membranes by surfactant apoprotein B. Biochim Biophys Acta 1998;1371:254–264.
  43. Pérez-Gil J, Casals C, Marsh D. Interactions of hydrophobic lung surfactant proteins SP-B and SP-C with dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylglycerol bilayers studied by electron spin resonance spectroscopy. Biochemistry 1995;34:3964–3971.

    External Resources

  44. Beck DC, Ikegami M, Na CL, Zaltash S, Johansson J, Whitsett JA, Weaver TE: The role of homodimers in surfactant protein B function in vivo. J Biol Chem 2000;275:3365–3370.
  45. Veldhuizen EJ, Waring AJ, Walther FJ, Batenburg JJ, van Golde LMG, Haagsman HP: Dimeric N-terminal segment of human surfactant protein B (dSP-B(1–25)) has enhanced surface properties compared to monomeric SP-B(1–25). Biophys J 2000;79:377–384.
  46. Kramer A, Wintergalen A, Sieber M, Galla HJ, Amrein M, Guckenberger R: Distribution of the surfactant-associated protein C within a lung surfactant model film investigated by near-field optical microscopy. Biophys J 2000;78:458–465.
  47. Plasencia I, Rivas L, Casals C, Keough KMW, Pérez-Gil J: Intrinsic structural differences in the N-terminal segment of pulmonary surfactant protein SP-C from different species. Comp Biochem Physiol 2001;129:129–139.
  48. Oosterlaken-Dijksterhuis MA, van Eijk M, van Golde LMG, Haagsman HP: Lipid mixing is mediated by the hydrophobic surfactant protein SP-B but not by SP-C. Biochim Biophys Acta 1992;1110:45–50.
  49. Perkins WR, Dause RB, Parente RA, Minchey SR, Neuman KC, Gruner SM, Taraschi TF, Janoff AS: Role of lipid polymorphism in pulmonary surfactant. Science 1996;273:330–332.
  50. Mohwald H: Phospholipid monolayers; in Lipowski R, Sackmann E (eds): Structure and Dynamics of Membranes: From Cells to Vesicles. Amsterdam, Elsevier, 1995, pp 161–211.
  51. Goerke J, Gonzales J: Temperature dependence of dipalmitoyl phosphatidylcholine monolayer stability. J Appl Physiol 1981;51:1108–1114.

    External Resources

  52. Bangham AD, Morley CJ, Phillips MC: The physical properties of an effective lung surfactant. Biochim Biophys Acta 1979;573:552–556.

    External Resources

  53. Nag K, Munro JG, Inchley K, Schürch S, Petersen NO, Possmayer F: SP-B refining of pulmonary surfactant phospholipid films. Am J Physiol 1999;277:L1179–L1189.

    External Resources

  54. Taneva S, Keough KMW: Pulmonary surfactant proteins SP-B and SP-C in spread monolayers at the air-water interface: II. Monolayers of pulmonary surfactant protein SP-C and phospholipids. Biophys J 1994;66:1149–1157.
  55. Schürch S, Bachofen H, Possmayer F: Surface activity in situ, in vivo, and in the captive bubble surfactometer. Comp Biochem Physiol 2001;129:195–207.
  56. Veldhuizen EJ, Batenburg JJ, van Golde LMG, Haagsman HP: The role of surfactant proteins in DPPC enrichment of surface films. Biophys J 2000;79:3164–3171.

    External Resources

  57. Yu SH, Possmayer F: Effect of pulmonary surfactant protein A and neutral lipid on accretion and organization of dipalmitoylphosphatidylcholine in surface films. J Lipid Res 1996;37:1278–1288.
  58. Discher BM, Maloney KM, Schief WR Jr, Grainger DW, Vogel V, Hall SB: Lateral phase separation in interfacial films of pulmonary surfactant. Biophys J 1996;71:2583–2590.
  59. Nag K, Pérez-Gil J, Ruano ML, Worthman LA, Stewart J, Casals C, Keough KMW: Phase transitions in films of lung surfactant at the air-water interface. Biophys J 1998;74:2983–2995.
  60. Discher BM, Schief WR, Vogel V, Hall SB: Phase separation in monolayers of pulmonary surfactant phospholipids at the air-water interface: composition and structure. Biophys J 1999;77:2051–2061.
  61. Piknova B, Schief WR, Vogel V, Discher BM, Hall SB: Discrepancy between phase behavior of lung surfactant phospholipids and the classical model of surfactant function. Biophys J 2001;81:2172–2180.

    External Resources

  62. Nag K, Taneva SG, Pérez-Gil J, Cruz A, Keough KMW: Combinations of fluorescently labeled pulmonary surfactant proteins SP-B and SP-C in phospholipid films. Biophys J 1997;72:2638–2650.
  63. Lipp MM, Lee KY, Zasadzinski JA, Waring AJ. Phase and morphology changes in lipid monolayers induced by SP-B protein and its amino-terminal peptide. Science 1996;273:1196–1199.
  64. Krol S, Ross M, Sieber M, Kunneke S, Galla HJ, Janshoff A: Formation of three-dimensional protein-lipid aggregates in monolayer films induced by surfactant protein B. Biophys J 2000;79:904–918.

    External Resources

  65. Gustafsson M, Palmblad M, Curstedt T, Johansson J, Schürch S: Palmitoylation of a pulmonary surfactant protein C analogue affects the surface associated lipid reservoir and film stability. Biochim Biophys Acta 2000;1466:169–178.
  66. Glasser SW, Burhans MS, Korfhagen TR, Na CL, Sly PD, Ross GF, Ikegami M, Whitsett JA: Altered stability of pulmonary surfactant in SP-C-deficient mice. Proc Natl Acad Sci USA 2001;98:6366–6371.
  67. Wright JR, Dobbs LG: Regulation of pulmonary surfactant secretion and clearance. Annu Rev Physiol 1991;53:395–414.
  68. Inchley K, Cockshutt A, Veldhuizen R, Possmayer F: Dissociation of surfactant protein B from canine surfactant large aggregates during formation of small surfactant aggregates by in vitro surface area cycling. Biochim Biophys Acta 1999;1440:49–58.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50